What's in ParaPRO LLC's pipeline?

ParaPRO LLC has 5 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with ParaPRO LLC's portfolio?

Top competitors by shared drug class: Sun Pharmaceutical Industries, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/parapro-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

ParaPRO LLC — Portfolio Competitive Intelligence Brief

ParaPRO LLC pipeline: 0 marketed, 0 filed, 2 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Permethrin 1%	Permethrin 1%	phase 3	pyrethroid	Voltage-gated sodium channels	Public Health
spinosad topical suspension, 0.9%	spinosad topical suspension, 0.9%	phase 3	Insecticide	Nicotinic acetylcholine receptor	Entomology

Therapeutic area mix

Entomology · 1
Public Health · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Sun Pharmaceutical Industries, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for ParaPRO LLC:

Cite this brief

Drug Landscape (2026). ParaPRO LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/parapro-llc. Accessed 2026-05-13.